The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Share News (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.17
Ask: 0.21
Change: 0.01 (5.56%)
Spread: 0.04 (23.529%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.18
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Nuformix responds to "frustration" as CEO departs

Thu, 22nd Jul 2021 14:29

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and not separately reported by Alliance News:

----------

Nuformix PLC - London-based pharmaceutical firm focused on fibrosis and oncology - Non-Executive Chair Alastair Riddell writes a letter to shareholders to address the "frustration and confusion" that followed Wednesday's announcement that Anne Brindley will depart as chief executive officer, having only joined Nuformix in December. Prior to Nuformix, Brindley was CEO of Advent Pharmaceuticals Pty Ltd, a Melbourne-based research and development company focused on generic inhaled products. Riddell says Brindley received a "significant job offer she could not refuse from previous colleagues – it is no reflection on Nuformix or her view of the opportunities in the Nuformix pipeline". Brindley will continue to push forward the company's three pipeline assets for NXP002, NXP004 and NXP001 during the six-month notice period. "All these projects are proceeding according to plan towards the inflection points previously communicated and all activities will continue to be progressed," Riddell says.

----------

AstraZeneca PLC - Cambridge, England-based biopharmaceutical firm - Appoints Andreas Rummelt as non-executive director. Rummelt had been a board member of Alexion Pharmaceuticals Inc since 2010. Astra completed the USD39 billion acquisition of Boston, Massachusetts-based Alexion on Wednesday. In his executive career, Rummelt was head of Technical Operations & Quality at Novartis AG. At the same time, Alexion CFO Aradhana Sarin moves to Astra as CFO and joins the board as an executive director.

----------

Sensyne Health PLC - Oxford, England-based clinical technology using artificial intelligence - Hires David Ruau into newly created role of chief scientific officer, starting September 1. Ruau joins from Germany's Bayer AG, where has been head of Global Data Assets & Decision Science since 2017. Prior to Bayer, Ruau was head of Scientific Computing Solutions at AstraZeneca.

----------

Getech Group PLC - Leeds-based provider of geoscience data and software to energy industry - Hires Emma Parker-Wilson as non-executive director, effective immediately and replacing Chris Flavel, who retires from the board. Parker-Wilson is principal in charge of Sustainable Business Opportunities at miner Anglo American PLC.

----------

LPA Group PLC - Saffron Walden, Essex-based LED lighting, electronic and electro-mechanical system designer and manufacturer - Confirms Peter Pollock will retire as chair and director from August 8, having served LPA for 24 years as chief executive and then executive chair. Recent board appointee Robert Horvath becomes independent chair.

----------

Valereum Blockchain PLC - Gibraltar-based blockchain technology builder - Patrick Young joins board as executive director, effective immediately. Young will help Valereum build the Valereum Bridge, a non-fungible-token bespoke securities financial platform aimed at linking government-issued currencies with cypto currencies. Young is author of a book on fintech and is former chair of the Blockchain Malta Association.

----------

Supply@Me Capital PLC - London-based inventory monetisation platform - Non-Executive Chair Dominic White steps down as director, effective Thursday, "to focus on his other business interests". A search for successor is underway.

----------

Providence Resources PLC - Barryroe oil and gas project offshore Ireland - Hires Peter Newman as senior independent director and Ann-Marie O'Sullivan as director, starting at the end of Thursday's annual general meeting. Newman was global head of Oil & Gas at accountants Deloitte and prior to that held a similar regional role at peer Arthur Andersen. O'Sullivan is public relations professional who has held board positions with Dublin Airport Authority and Cork Chamber of Commerce. The Barryroe project is in the Atlantic Ocean south of Cork.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Oct 2019 12:27

Nuformix Confirms Japan, Asia Licencing Talks As Shares Surge

Nuformix Confirms Japan, Asia Licencing Talks As Shares Surge

Read more
10 Sep 2019 13:47

Nuformix Chief Financial Officer Kirk Siderman-Wolter Resigns Abruptly

(Alliance News) - Pharmaceutical company Nuformix PLC on Tuesday said Chief Financial Officer and Senior Independent Non-Executive Director Kirk Siderman-Wolter has resigned with immediate company

Read more
9 Sep 2019 11:25

Nuformix, Ebers Tech File Patent For Cannabinoid Cocrystals

(Alliance News) - Pharmaceutical company Nuformix PLC on Monday said it and partner Ebers Tech Inc have filed the first patent in relation to cannabinoid cocrystals.The patented cannabinoid

Read more
6 Sep 2019 12:17

Nuformix Hires Cambridge Interstitial Lung Disease Unit Lead Clinician

(Alliance News) - Nuformix PLC said on Friday it has appointed Muhunthan Thillai to its scientific advisory board with immediate effect.Thillai is the lead clinician for the Cambridge Lung

Read more
18 Jul 2019 11:16

Nuformix Annual Loss Narrows As Revenue Jumps On NXP001 Progress

(Alliance News) - Nuformix PLC on Thursday said its revenue multiplied in its most recently-ended financial year as it has secured its first licensing income from NXP001.NXP001 is one of in

Read more
30 May 2019 10:33

WINNERS & LOSERS SUMMARY: De La Rue Down As CEO Exits And Profit Falls

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - LOSERS----------National a

Read more
30 May 2019 10:14

Nuformix Shares Jump On Positive NXP001 Clinical Study Results

LONDON (Alliance News) - Shares in Nuformix PLC surged on Thursday as the company reported positive results in its clinical study of NXP001.Nuformix shares were trading 30% higher at 13.50

Read more
9 Apr 2019 11:25

Nuformix inks cannabinoid therapeutics deal with Ebers Tech

(Sharecast News) - Pharmaceutical development company Nuformix has inked an agreement for cannabinoid therapeutics development, licensing and commercialisation with Canadian outfit Ebers Tech.

Read more
9 Apr 2019 10:46

WINNERS & LOSERS SUMMARY: 7digital Warns Of Need For Capital Raise

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Anglo up -

Read more
22 Mar 2019 08:50

Nuformix Doses First Patient In NXP001 Anti-Nausea Drug Trial

LONDON (Alliance News) - Nuformix PLC on Friday said it has begun clinical studies for its anti-nausea drug NXP001 and dosed its first patient.Shares in Nuformix were down 4.6% at 2.10 on a

Read more
27 Feb 2019 10:48

MHRA gives go-ahead to Nuformix for human studies

(Sharecast News) - Pharmaceutical development company Nuformix has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to begin human pharmacokinetics studies for its lead asset, NXP001, it announced on Wednesday.

Read more
3 Dec 2018 09:53

Nuformix Reports Positive Results From NXP002 Pre-Clinical Trial

LONDON (Alliance News) - Pharmaceutical development firm Nuformix PLC on Monday reported positive results from its completed NXP002 fibrosis programme pre-clinical trial for the treatment of a of

Read more
27 Nov 2018 10:04

Nuformix Expands NXP001 Agreement With Additional Pre-Clinical Study

LONDON (Alliance News) - Pharmaceutical development firm Nuformix PLC said on Tuesday it has expanded its current licensing agreement with partner Newsummit Biopharma for the development of cancer

Read more
14 Sep 2018 10:17

Nuformix Rises As NXP001 Passes "Major" Pre-Clinical Milestone

LONDON (Alliance News) - Shares in pharmaceutical firm Nuformix PLC rose Friday it has received a GBP500,000 payment after its NXP001 product reached a pre-clinical milestone.Nuformix was a

Read more
12 Sep 2018 16:00

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 13 SeptemberBahamas PetroleumFlybe GroupBetter Capital PCCWorldwide 14 UK 17

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.